{"denoms":[{"counts":[{"groupId":"BG000","value":"338"},{"groupId":"BG001","value":"335"},{"groupId":"BG002","value":"673"}],"units":"Participants"}],"groups":[{"description":"All participants who were enrolled in Osimertinib Arm for either the global or China Extension study.","id":"BG000","title":"Global + China Extension Osimertinib Arm"},{"description":"All participants who were enrolled in SoC EGFR-TKI Arm for either the Global or China Extension study","id":"BG001","title":"Global + China Extension SoC EGFR-TKI Arm"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"10.70","value":"62.7"},{"groupId":"BG001","spread":"10.90","value":"63.3"},{"groupId":"BG002","spread":"10.79","value":"63.0"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"279"},{"groupId":"BG001","value":"277"},{"groupId":"BG002","value":"556"}],"units":"Participants"}],"title":"Global cohort"},{"categories":[{"measurements":[{"groupId":"BG000","spread":"9.66","value":"59.1"},{"groupId":"BG001","spread":"10.94","value":"59.0"},{"groupId":"BG002","spread":"10.26","value":"59.0"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"71"},{"groupId":"BG001","value":"65"},{"groupId":"BG002","value":"136"}],"units":"Participants"}],"title":"China Cohort"}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"Each study is reported in a seprate row. There were 12 participants who were in both the Global and China Extension Osimertinib Arm, and 7 particicpants in both the Global and China Extension SoC EGFR-TKI arm.","title":"Age, Continuous","unitOfMeasure":"Years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"178"},{"groupId":"BG001","value":"172"},{"groupId":"BG002","value":"350"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"101"},{"groupId":"BG001","value":"105"},{"groupId":"BG002","value":"206"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"279"},{"groupId":"BG001","value":"277"},{"groupId":"BG002","value":"556"}],"units":"Participants"}],"title":"Global cohort"},{"categories":[{"measurements":[{"groupId":"BG000","value":"43"},{"groupId":"BG001","value":"46"},{"groupId":"BG002","value":"89"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"28"},{"groupId":"BG001","value":"19"},{"groupId":"BG002","value":"47"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"71"},{"groupId":"BG001","value":"65"},{"groupId":"BG002","value":"136"}],"units":"Participants"}],"title":"China Cohort"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Each study is reported in a seprate row. There were 12 participants who were in both the Global and China Extension Osimertinib Arm, and 7 particicpants in both the Global and China Extension SoC EGFR-TKI arm.","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"174"},{"groupId":"BG001","value":"173"},{"groupId":"BG002","value":"347"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"4"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"101"},{"groupId":"BG001","value":"100"},{"groupId":"BG002","value":"201"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}],"title":"Unknown or Not Reported"}],"denoms":[{"counts":[{"groupId":"BG000","value":"279"},{"groupId":"BG001","value":"277"},{"groupId":"BG002","value":"556"}],"units":"Participants"}],"title":"Global Cohort"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"71"},{"groupId":"BG001","value":"65"},{"groupId":"BG002","value":"136"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Unknown or Not Reported"}],"denoms":[{"counts":[{"groupId":"BG000","value":"71"},{"groupId":"BG001","value":"65"},{"groupId":"BG002","value":"136"}],"units":"Participants"}],"title":"China Cohort"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Each study is reported in a seprate row. There were 12 participants who were in both the Global and China Extension Osimertinib Arm, and 7 particicpants in both the Global and China Extension SoC EGFR-TKI arm.","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"77"},{"groupId":"BG001","value":"94"},{"groupId":"BG002","value":"171"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"279"},{"groupId":"BG001","value":"277"},{"groupId":"BG002","value":"556"}],"units":"Participants"}],"title":"Asian-Global Cohort"},{"categories":[{"measurements":[{"groupId":"BG000","value":"32"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"56"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"279"},{"groupId":"BG001","value":"277"},{"groupId":"BG002","value":"556"}],"units":"Participants"}],"title":"Chinese-Global Cohort"},{"categories":[{"measurements":[{"groupId":"BG000","value":"65"},{"groupId":"BG001","value":"55"},{"groupId":"BG002","value":"120"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"279"},{"groupId":"BG001","value":"277"},{"groupId":"BG002","value":"556"}],"units":"Participants"}],"title":"Japanese-Global Cohort"},{"categories":[{"measurements":[{"groupId":"BG000","value":"103"},{"groupId":"BG001","value":"104"},{"groupId":"BG002","value":"207"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"279"},{"groupId":"BG001","value":"277"},{"groupId":"BG002","value":"556"}],"units":"Participants"}],"title":"Other-Global Cohort"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"2"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"279"},{"groupId":"BG001","value":"277"},{"groupId":"BG002","value":"556"}],"units":"Participants"}],"title":"Missing-Global Cohort"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"279"},{"groupId":"BG001","value":"277"},{"groupId":"BG002","value":"556"}],"units":"Participants"}],"title":"Hispanic or Latino-Global Cohort"},{"categories":[{"measurements":[{"groupId":"BG000","value":"71"},{"groupId":"BG001","value":"65"},{"groupId":"BG002","value":"136"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"71"},{"groupId":"BG001","value":"65"},{"groupId":"BG002","value":"136"}],"units":"Participants"}],"title":"Chinese-China cohort"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Each study is reported in a seprate row. There were 12 participants who were in both the Global and China Extension Osimertinib Arm, and 7 particicpants in both the Global and China Extension SoC EGFR-TKI arm.","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"182"},{"groupId":"BG001","value":"175"},{"groupId":"BG002","value":"357"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"279"},{"groupId":"BG001","value":"277"},{"groupId":"BG002","value":"556"}],"units":"Participants"}],"title":"Never smoked-Global Cohort"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"17"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"279"},{"groupId":"BG001","value":"277"},{"groupId":"BG002","value":"556"}],"units":"Participants"}],"title":"Current smokers-Global Cohort"},{"categories":[{"measurements":[{"groupId":"BG000","value":"89"},{"groupId":"BG001","value":"93"},{"groupId":"BG002","value":"182"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"279"},{"groupId":"BG001","value":"277"},{"groupId":"BG002","value":"556"}],"units":"Participants"}],"title":"Former smokers-Global Cohort"},{"categories":[{"measurements":[{"groupId":"BG000","value":"53"},{"groupId":"BG001","value":"50"},{"groupId":"BG002","value":"103"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"71"},{"groupId":"BG001","value":"65"},{"groupId":"BG002","value":"136"}],"units":"Participants"}],"title":"Never smoked-China Cohort"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"7"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"71"},{"groupId":"BG001","value":"65"},{"groupId":"BG002","value":"136"}],"units":"Participants"}],"title":"Current smokers-China Cohort"},{"categories":[{"measurements":[{"groupId":"BG000","value":"15"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"26"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"71"},{"groupId":"BG001","value":"65"},{"groupId":"BG002","value":"136"}],"units":"Participants"}],"title":"Former smokers-China Cohort"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Each study is reported in a seprate row. There were 12 participants who were in both the Global and China Extension Osimertinib Arm, and 7 particicpants in both the Global and China Extension SoC EGFR-TKI arm.","title":"Smoking status","unitOfMeasure":"Participants"}],"populationDescription":"There were 12 participants who were in both the Global and China Extension Osimertinib Arm and 7 participants in both the Global and China Extension SoC EGFR-TKI arm."}